Imunon, Inc. Faces Delisting Concerns
Ticker: IMNN · Form: 8-K · Filed: May 20, 2025 · CIK: 749647
Sentiment: bearish
Topics: delisting, listing-standards
TL;DR
Imunon's in hot water with the exchange, might get delisted.
AI Summary
Imunon, Inc. filed an 8-K on May 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.
Why It Matters
This filing indicates potential issues with Imunon, Inc.'s ability to remain listed on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and stock viability.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- May 19, 2025 (date) — Earliest event reported
- May 20, 2025 (date) — Date of report
- 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311 (address) — Principal executive offices
FAQ
What specific listing rule or standard has Imunon, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Imunon, Inc. has failed to satisfy, only that a notice has been issued.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is May 19, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.
What is the Commission File Number for Imunon, Inc.?
The Commission File Number for Imunon, Inc. is 001-15911.
Has Imunon, Inc. undergone any previous name changes?
Yes, Imunon, Inc. was formerly known as Celsion Corp (name change on 20071121 and 19980515) and Cheung Laboratories Inc (name change on 19920703).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Imunon, Inc. (IMNN).